[1]
Li, M. and Cescon, D.W. 2024. From Intractable to Treatable: Milestones and Horizons in the Management of HER2+ Breast Cancer. Canadian Oncology Today. 1, 2 (Jun. 2024), 20–26. DOI:https://doi.org/10.58931/cot.2024.1222.